Assay Detail
Functional
CHEMBL4375038
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Cytotoxicity against human plasmablasts assessed as reduction in cell viability by CellTiter Glo assay
5
Total Activities
5
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Functional |
| Organism | Homo sapiens |
| Confidence | 0 — Uncurated / Unknown |
| Curated By | Autocuration |
Publication
Design and Evaluation of Highly Selective Human Immunoproteasome Inhibitors Reveal a Compensatory Process That Preserves Immune Cell Viability.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| IC50 | 5 | 6.48 | 8.41 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL325041 | BORTEZOMIB | 3.0 | 1 | 8.41 |
| CHEMBL4580854 | — | — | 1 | 7.27 |
| CHEMBL4471761 | — | — | 1 | 6.17 |
| CHEMBL4437785 | — | — | 1 | 5.54 |
| CHEMBL4458214 | — | — | 1 | 5.03 |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL325041 | BORTEZOMIB | IC50 | = | 3.9 | nM | 8.41 |
| CHEMBL4580854 | — | IC50 | = | 54.0 | nM | 7.27 |
| CHEMBL4471761 | — | IC50 | = | 670.0 | nM | 6.17 |
| CHEMBL4437785 | — | IC50 | = | 2900.0 | nM | 5.54 |
| CHEMBL4458214 | — | IC50 | = | 9300.0 | nM | 5.03 |